CAO, JUN,ERB, BERNHARD,FAIRHURST, ROBIN ALEC,GRANDEURY, ARNAUD,HATAKEYAMA, SHINJI,KOZICZAK-HOLBRO, MAGDALENA,LAI, XINZHONG,LUSTENBERGER, PHILLIP,RIEBESEHL, BERND,TUFILLI, NICOLA,ULLRICH, THOMAS,WU, XI
申请号：
PE2014000312
公开号：
PE20141993A1
申请日:
2012.09.05
申请国别(地区):
PE
年份:
2014
代理人:
摘要：
It refers to a formula compound (R) - 7 - (2 - (1 - (4-butoxyphenyl) - 2-methylpropane-2-acetamide) - 1-hydroxy-1-hydroxy-5-hydroxybenzene-2 (3H) - ona. He also mentioned a pharmacological synthesis that is characterized by use in the treatment or prevention of muscular atrophy, Kakha or scabies.REFERIDO A UN COMPUESTO DE FORMULA (R)-7-(2-(1-(4-BUTOXIFENIL)-2-METILPROPAN-2-ILAMINO)-1-HIDROXIETIL)-5-HIDROXIBENZO[D]TIAZOL-2(3H)-ONA. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA, CARACTERIZADA POR SU APLICACION PARA EL TRATAMIENTO O LA PREVENCION DE LA DISTROFIA MUSCULAR, CAQUEXIA O SARCOPENIA
